Merck's latest earnings call revealed a mix of growth and pain points for the pharmaceutical giant.

Kennedy Jr., a vocal vaccine skeptic and activist lawyer, appeared on track to become the nation's health secretary after ...

Robert F. Kennedy Jr.'s nomination for US health secretary advances with crucial Republican support, despite controversy over ...

Merck shares tumbled Tuesday morning after the drugmaker's soft outlook outweighed fourth-quarter revenue and adjusted profits topping expectations.

Robert F. Kennedy Jr. has cleared his first hurdle to become the nation’s top health official as the Senate finance committee ...